LLMs an as Analyst II (work in progress)

Sunday May 2, 2026

What I am trying to do is automate the last process I do when selecting stocks.

It has been quite difficult to get an LLM to actually produce valid analysis. Had to use an adversarial approach to get anywhere. The bias in LLMs is very hard to mitigate.

Here are two example snip-its for Ernexa Therapeutics and C4 Therapeutics (which we own.)